Home | Current Issue | Past Issues | Search | CollectionsRSS | PDA Services | FAQ | SHCIM Online | Chinese Updated Tuesday, July 29, 2014
 Services
Submit a manuscript
Subscribe
Individuals
Institutions
Response
Send response
Read responses
Reprint
Advance online publication
Sign up for e-alert
JCIM job opportunities
Contact JCIM
 Information For
Readers
Authors
Reviewers
Advertisers
 About JCIM
Journal description
Editorial policy
Privacy policy
Copy right
Editorial staff
 Language Polishing
Journal of Chinese Integrative Medicine: 2010; 8(4): 301-306
DOI: 10.3736/jcim20100401
Real-world study: a potential new approach to effectiveness evaluation of traditional Chinese medicine interventions
1. Feng TIAN (Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China E-mail: zhinanb2005@yahoo.com.cn)
2. Yan-ming XIE (Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China )
Abstract: Some conclusions drawn from explanatory randomized controlled trial (ERCT) lack practical value in application under real-world clinical settings, and there are also some limitations on the generalization of pragmatic randomized controlled trial (PRCT) results. In some countries, real-world studies (RWSs) have been conducted to explore the effectiveness and safety of clinical interventions or postmarketing drugs, which is a new tendency in clinical researches. By reviewing some RWSs carried out in Western countries, we sum up the basic characteristics of the research design, and discuss the differences and connections between PRCT and RWS. The design ideas of RWS are different from PRCT. Researchers in RWS tend to perform long-term evaluation based on large quantities of subjects and quite large sample and focus on outcome measures which are clinically meaningful. Strict control on data collection, management and analysis are very important to RWS and PRCT. Owing to the complexity of clinical interventions and evaluation, PRCT is not completely suitable for clinical researches in traditional Chinese medicine (TCM). It is an inevitable tendency to apply RWS in clinical trials of TCM. We can explore the efficacy of TCM interventions through PRCT, and better understand the effectiveness through RWS. RWS will become a powerful approach to TCM clinical trials and postmarketing evaluation of Chinese medicines.
Welcome to JCIM! You are the number 7192 reader of this article!
Download Article:
[Full Text]      [PDF]      [Chinese]      [Next]      [This Issue]
Please cite this article as:
Tian F, Xie YM. Real-world study: a potential new approach to effectiveness evaluation of traditional Chinese medicine interventions. J Chin Integr Med / Zhong Xi Yi Jie He Xue Bao. 2010; 8(4): 301-306.
References:
1Sharpe N. Clinical trials and the real world: selection bias and generalisability of trial results[J].Cardiovasc Drugs Ther, 2002, 16(16): 75-77.  .
2Grapow MT, von Wattenwyl R, Guller U, Beyersdorf F, Zerkowski HR. Randomized controlled trials do not reflect reality: real-world analyses are critical for treatment guidelines[J].J Thorac Cardiovasc Surg, 2006, 132(1): 5-7.  .
3Godwin M, Ruhland L, Casson I, MacDonald S, Delva D, Birtwhistle R, Lam M, Seguin R. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity[J].BMC Med Res Methodol, 2003, 3: 28.  .
4Karanicolas PJ, Montori VM, Devereaux PJ, Schünemann H, Guyatt GH. A new “mechanistic-practical” framework for designing and interpreting randomized trials[J].J Clin Epidemiol, 2009, 62(5): 479-484.  .
5Fox KAA. An introduction to the global registry of acute coronary events[J].GRACE. Eur Heart J, 2000, 2(Suppl F): F21-F24.  .
6Mossello E, Tonon E, Caleri V, Tilli S, Cantini C, Cavallini MC, Bencini F, Mecacci R, Marini M, Bardelli F, Sarcone E, Razzi E, Biagini CA, Masotti G. Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimers disease: a “real world” study[J].Arch Gerontol Geriatr Suppl, 2004, (9): 297-307.  .
7Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I, Accordini S, Almar E, Bugiani M, Carolei A, Cerveri I, Duran-Tauleria E, Gislason D, Gulsvik A, Jogi R, Marinoni A, Martinez-Moratalla J, Vermeire P, de-Marco R. Asthma control in Europe: a real-world evaluation based on an international population-based study[J].J Allergy Clin Immunol, 2007, 120(6): 1360-1367.  .
8Gale CP, Manda SOM, Batin PD, Weston CF, Birkhead JS, Hall AS. Predictors of in-hospital mortality for patients admitted with ST-elevation myocardial infarction: a real-world study using the Myocardial Infarction National Audit Project (MINAP) database[J].Heart, 2008, 94(11): 1407-1412.  .
9Lasalvia A, Bonetto C, Cristofalo D, Tansella M, Ruggeri M. Predicting clinical and social outcome of patients attending real world mental health services: a 6-year multi-wave follow-up study[J].Acta Psychiatr Scand Suppl, 2007, (437): 16-30.  .
10Gartlehner G, Hansen RA, Nissman D, Lohr KN, Carey TS. A simple and valid tool distinguished efficacy from effectiveness studies[J].J Clin Epidemiol, 2006, 59(10): 1040-1048.  .
11Fleischhacker WW, Goodwin GM. Effectiveness as an outcome measure for treatment trials in psychiatry[J].World Psychiatry, 2009, 8(1): 23-27.  .
12Magliano L, Fiorillo A, Malangone C, Rosa CD, Maj M. Patient functioning and family burden in a controlled, real-world trial of family psychoeducation for schizophrenia[J].Psychiatr Serv, 2006, 57(12): 1784-1791.  .
13Vidal JS, Lacombe JM, Dartigues JF, Pasquier F, Robert P, Tzourio C, Alpérovitch A. Memantine therapy for Alzheimer disease in real-world practice: an observational study in a large representative sample of French patients[J].Alzheimer Dis Assoc Disord, 2008, 22(2): 125-130.  .
14Kraemer HC. “Rules” of evidence in assessing the efficacy and effectiveness of treatments[J].Dev Neuropsychol, 2003, 24(2-3): 705-718.  .
15GRACE Investigators. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes[J].Am Heart J, 2001, 141(2): 190-199.  .
16Farahani P, Levine M, Gaebel K, Khalidi N, Wang ECY. Community-based evaluation of etanercept in patients with rheumatoid arthritis[J].J Rheumatol, 2006, 33(4): 665-670.  .
17Nash JM, McCrory D, Nicholson RA, Andrasik F. Efficacy and effectiveness approaches in behavioral treatment trials[J].Headache, 2005, 45(5): 507-512.  .
18Ernst E, Canter PH. Limitations of “pragmatic” trials[J].Postgrad Med J, 2005, 81(954): 203.  .
19Simon G, Wagner E, Vonkorff M. Cost-effectiveness comparisons using “real world” randomized trials: the case of antidepressant drugs[J].J Clin Epidemiol, 1995, 48(3): 363-373.  .

 Home | Current Issue | Past Issues | Search | CollectionsRSS | PDA Services | FAQ | SHCIM Online | Chinese
Copyright © 2003-2012 by JCIM Press. All rights reserved. ISSN 1672-1977